Literature DB >> 31088869

Managing opioid use disorder in primary care: PEER simplified guideline.

Christina Korownyk1, Danielle Perry2, Joey Ton3, Michael R Kolber4, Scott Garrison5, Betsy Thomas6, G Michael Allan7, Cheryl Bateman8, Raquel de Queiroz9, Dorcas Kennedy10, Wiplove Lamba11, Jazmin Marlinga12, Tally Mogus13, Tony Nickonchuk14, Eli Orrantia15, Kim Reich16, Nick Wong17, Nicolas Dugré18, Adrienne J Lindblad19.   

Abstract

OBJECTIVE: To use the best available evidence and principles of shared, informed decision making to develop a clinical practice guideline for a simplified approach to managing opioid use disorder (OUD) in primary care.
METHODS: Eleven health care and allied health professionals representing various practice settings, professions, and locations created a list of key questions relevant to the management of OUD in primary care. These questions related to the treatment setting, diagnosis, treatment, and management of comorbidities in OUD. The questions were researched by a team with expertise in evidence evaluation using a series of systematic reviews of randomized controlled trials. The Guideline Committee used the systematic reviews to create recommendations. RECOMMENDATIONS: Recommendations outline the role of primary care in treating patients with OUD, as well as pharmacologic and psychotherapy treatments and various prescribing practices (eg, urine drug testing and contracts). Specific recommendations could not be made for management of comorbidities in patients with OUD owing to limited evidence.
CONCLUSION: The recommendations will help simplify the complex management of patients with OUD in primary care. They will aid clinicians and patients in making informed decisions regarding their care. Copyright© the College of Family Physicians of Canada.

Entities:  

Year:  2019        PMID: 31088869      PMCID: PMC6516701     

Source DB:  PubMed          Journal:  Can Fam Physician        ISSN: 0008-350X            Impact factor:   3.275


  17 in total

Review 1.  Development of dependence following treatment with opioid analgesics for pain relief: a systematic review.

Authors:  Silvia Minozzi; Laura Amato; Marina Davoli
Journal:  Addiction       Date:  2012-10-18       Impact factor: 6.526

2.  Incidence of iatrogenic opioid dependence or abuse in patients with pain who were exposed to opioid analgesic therapy: a systematic review and meta-analysis.

Authors:  C Higgins; B H Smith; K Matthews
Journal:  Br J Anaesth       Date:  2018-04-21       Impact factor: 9.166

3.  Prescription opioid use: Patient characteristics and misuse in community pharmacy.

Authors:  Gerald Cochran; Jennifer L Bacci; Thomas Ylioja; Valerie Hruschak; Sharon Miller; Amy L Seybert; Ralph Tarter
Journal:  J Am Pharm Assoc (2003)       Date:  2016-03-24

4.  Prevalence of prescription opioid use disorder among chronic opioid therapy patients after health plan opioid dose and risk reduction initiatives.

Authors:  Michael Von Korff; Rod L Walker; Kathleen Saunders; Susan M Shortreed; Manu Thakral; Michael Parchman; Ryan N Hansen; Evette Ludman; Karen J Sherman; Sascha Dublin
Journal:  Int J Drug Policy       Date:  2017-06-27

5.  Comparing the contribution of prescribed opioids to opioid-related hospitalizations across Canada: A multi-jurisdictional cross-sectional study.

Authors:  Tara Gomes; Wayne Khuu; Diana Craiovan; Diana Martins; Jordan Hunt; Kathy Lee; Mina Tadrous; Muhammad M Mamdani; J Michael Paterson; David N Juurlink
Journal:  Drug Alcohol Depend       Date:  2018-07-31       Impact factor: 4.492

6.  GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations.

Authors:  Jeff Andrews; Gordon Guyatt; Andrew D Oxman; Phil Alderson; Philipp Dahm; Yngve Falck-Ytter; Mona Nasser; Joerg Meerpohl; Piet N Post; Regina Kunz; Jan Brozek; Gunn Vist; David Rind; Elie A Akl; Holger J Schünemann
Journal:  J Clin Epidemiol       Date:  2013-01-09       Impact factor: 6.437

7.  Simplified lipid guidelines: Prevention and management of cardiovascular disease in primary care.

Authors:  G Michael Allan; Adrienne J Lindblad; Ann Comeau; John Coppola; Brianne Hudson; Marco Mannarino; Cindy McMinis; Raj Padwal; Christine Schelstraete; Kelly Zarnke; Scott Garrison; Candra Cotton; Christina Korownyk; James McCormack; Sharon Nickel; Michael R Kolber
Journal:  Can Fam Physician       Date:  2015-10       Impact factor: 3.275

8.  Classification and identification of opioid addiction in chronic pain patients.

Authors:  Jette Højsted; Per Rotbøll Nielsen; Sally Kendall Guldstrand; Liv Frich; Per Sjøgren
Journal:  Eur J Pain       Date:  2010-05-21       Impact factor: 3.931

9.  Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study.

Authors:  Louisa Degenhardt; Raimondo Bruno; Nicholas Lintzeris; Wayne Hall; Suzanne Nielsen; Briony Larance; Milton Cohen; Gabrielle Campbell
Journal:  Lancet Psychiatry       Date:  2015-03-31       Impact factor: 27.083

10.  Risk of opioid misuse in chronic non-cancer pain in primary care patients - a cross sectional study.

Authors:  Johannes Maximilian Just; Linda Bingener; Markus Bleckwenn; Rieke Schnakenberg; Klaus Weckbecker
Journal:  BMC Fam Pract       Date:  2018-06-20       Impact factor: 2.497

View more
  17 in total

1.  The opioid crisis: getting to "better".

Authors:  Francine Lemire
Journal:  Can Fam Physician       Date:  2019-06       Impact factor: 3.275

2. 

Authors:  Radhika Marwah; Caitlin Coons; Jacqueline Myers; Zack Dumont
Journal:  Can Fam Physician       Date:  2020-12       Impact factor: 3.275

3. 

Authors:  Kevin Pottie; Claire E Kendall; Tim Aubry; Olivia Magwood; Anne Andermann; Ginetta Salvalaggio; David Ponka; Gary Bloch; Vanessa Brcic; Eric Agbata; Kednapa Thavorn; Terry Hannigan; Andrew Bond; Susan Crouse; Ritika Goel; Esther Shoemaker; Jean Zhuo Jing Wang; Sebastian Mott; Harneel Kaur; Christine Mathew; Syeda Shanza Hashmi; Ammar Saad; Thomas Piggott; Neil Arya; Nicole Kozloff; Michaela Beder; Dale Guenter; Wendy Muckle; Stephen Hwang; Vicky Stergiopoulos; Peter Tugwell
Journal:  CMAJ       Date:  2020-10-13       Impact factor: 8.262

4.  Incidence of iatrogenic opioid use disorder.

Authors:  Samantha Moe; Jessica Kirkwood; G Michael Allan
Journal:  Can Fam Physician       Date:  2019-10       Impact factor: 3.275

5. 

Authors:  Samantha Moe; Jessica Kirkwood; G Michael Allan
Journal:  Can Fam Physician       Date:  2019-10       Impact factor: 3.275

6.  Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines.

Authors:  Susan L Calcaterra; Richard Bottner; Marlene Martin; Honora Englander; Zoe M Weinstein; Melissa B Weimer; Eugene Lambert; Matthew V Ronan; Sergio Huerta; Tauheed Zaman; Monish Ullal; Alyssa F Peterkin; Kristine Torres-Lockhart; Megan Buresh; Meghan T O'Brien; Hannah Snyder; Shoshana J Herzig
Journal:  J Hosp Med       Date:  2022-07-26       Impact factor: 2.899

7.  High prevalence of unmet healthcare need among people who use illicit drugs in a Canadian setting with publicly-funded interdisciplinary primary care clinics.

Authors:  Soroush Moallef; Fahmida Homayra; M-J Milloy; Lorna Bird; Bohdan Nosyk; Kanna Hayashi
Journal:  Subst Abus       Date:  2020-12-03       Impact factor: 3.716

8. 

Authors:  Radhika Marwah; Caitlin Coons; Jacqueline Myers; Zack Dumont
Journal:  Can Fam Physician       Date:  2020-12       Impact factor: 3.275

Review 9.  Identification and Management of Opioid Use Disorder in Primary Care: an Update.

Authors:  Joseph H Donroe; Elenore P Bhatraju; Judith I Tsui; E Jennifer Edelman
Journal:  Curr Psychiatry Rep       Date:  2020-04-13       Impact factor: 5.285

10.  Prospective Study on Factors Associated with Referral of Patients with Opioid Maintenance Therapy from Specialized Addictive Disorders Centers to Primary Care.

Authors:  Morgane Guillou-Landreat; Philippe Levassor; Marylène Guerlais; Veronique Sebille; Caroline Victorri-Vigneau
Journal:  Int J Environ Res Public Health       Date:  2021-05-27       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.